To examine whether reduced rates of oxidative (G0x) and nonoxidative (N.x) glucose metabolism in non-insulin-dependent diabetes mellitus (NIDDM) are due to reduced glucose uptake, intrinsic defects in intracellular glucose metabolism or increased fat oxidation (Fox), indirect calorimetry was performed at similar glucose uptake rates in eight nonobese NIDDM and eight comparable nondiabetic subjects. Three glucose clamp studies were performed: one in the nondiabetic and two in the NIDDM subjects. In the nondiabetic subjects, glucose uptake was increased to 7.62±0.62 mg/kg of fat-free mass (FFM) per min by increasing serum insulin to 309 pmol/liter at a glucose concentration of 5.1 mmol/liter. By raising the concentration of either serum glucose or insulin fourfold in the NIDDM subjects, glucose uptake was matched to nondiabetic subjects (8.62±0.49 and 8.59±0.51 mg/kg FFM per min, respectively, P = NS). Skeletal muscle glycogen synthase activity and plasma lactate levels were measured to characterize N0X.
Introduction
Under normal circumstances insulin stimulates peripheral tissues, most notably skeletal muscle (1) , to take up glucose which is then metabolized by either oxidative or nonoxidative pathways. In non-insulin-dependent diabetes mellitus (NIDDM),' peripheral insulin resistance is a characteristic feature which impairs insulin's ability to stimulate glucose uptake and is associated with multiple abnormalities in intracellular glucose metabolism. Although defects in both oxidative and nonoxidative glucose metabolism have been demonstrated in NIDDM (2-7), current evidence indicates that the nonoxidative pathways are more significantly affected. This conclusion is based on the close correlations which have been demonstrated between defects in glucose uptake and nonoxi-' dative glucose metabolism (7) (8) (9) (10) . Additional correlations between glucose uptake and the activity of the rate-limiting enzyme for glycogen synthesis (glycogen synthase) (7, 10, 11) , plus the similarity in the sensitivity of glucose uptake and glycogen synthase for insulin ( 12) have led several investigators to further speculate that defects in the nonoxidative glycogen synthesis pathway may be the cause of the reduced rates of glucose uptake present in NIDDM and other states of insulin resistance (7, (10) (11) (12) (13) (14) (15) .
The conclusions drawn from these studies can be questioned, however, for the following reasons. First, reduced rates of intracellular glucose metabolism may be a consequence rather than a cause of reduced rates of tissue glucose uptake. That is, because of impaired insulin-mediated glucose uptake, less intracellular glucose than normal is available to traverse these metabolic pathways in NIDDM. Alternatively, since both glucose uptake and glycogen synthase can be stimulated by insulin, a simple correlation between these two processes does not necessarily indicate a cause and effect relationship. In support of this notion, there is some experimental evidence (16) (17) (18) (19) (20) that defects in insulin's effects on intracellular glucose metabolism may exist independent of the defect in insulinmediated glucose uptake.
To investigate whether the reduced rates of oxidative and nonoxidative glucose metabolism previously found in NIDDM are the result of reduced rates of glucose uptake or intrinsic defects in intracellular glucose metabolism, we carried out comparative studies in eight nonobese male subjects with and without NIDDM. Rates of oxidative and nonoxidative glucose metabolism were measured using indirect calorimetry in the basal state and at the same rate of glucose uptake in both groups. Glucose uptake was increased in the NIDDM subjects by increasing either the serum glucose or insulin fourfold that of nondiabetic control subjects using the combined pancreatic-glucose clamp technique. Assuming that glycogen synthase is the major determinant of glycogen deposition in muscle (7), we estimated the contribution of glycogen synthesis to nonoxidative glucose metabolism by measuring glycogen synthase activity in biopsies ofskeletal muscle in all subjects at the end of the basal and glucose clamp studies. Circulating plasma lactate levels were also measured to further characterize the composition ofN05. Fat oxidation was also measured to examine whether defects in glucose oxidation might be the result of increased fat oxidation as previously reported in NIDDM (21, 22).
Methods
Subjects. Eight male nonobese subjects with NIDDM and eight male nonobese control subjects with normal glucose tolerance (23) participated in the studies. The clinical and metabolic characteristics of the subjects are listed in Table I . Age, weight, fat-free mass (FFM, 24) , and body mass index did not differ in the NIDDM and control subjects. Fasting serum glucose in the NIDDM subjects was twice that of the controls (P < 0.005); fasting serum insulin was 78% greater (P < 0.05). The NIDDM subjects were healthy, except for diabetes, and did not have significant diabetic complications or hypertension. Five subjects were on sulfonylurea therapy, one was on insulin, one was on diet therapy only, and one had just been diagnosed and not yet treated. Oral hypoglycemic agents and insulin were withdrawn at least 2 wk before the studies. No subject was taking any other medication known to affect carbohydrate metabolism. Duration of overt diabetes was 10±3 yr (mean±SEM). Fasting glycosylated hemoglobin in the NIDDM subjects was 9.4±1.2%. The control subjects were screened to ensure they were healthy and had no family history of diabetes. Written informed consent was obtained from each subject. The experimental protocol was approved by the Committee on Human Investigation of the University of California, San Diego.
Study protocol. Subjects were admitted to the Special Diagnostic and Treatment Unit ofthe Veterans Administration Medical Center in San Diego and consumed a weight-maintenance standardized solid diet containing 55% ofcalories as carbohydrate, 30% as fat, and 15% as protein for at least 24 h before each study.
Three studies were performed, one in the control subjects and two in the NIDDM subjects. Each study consisted of a basal (i.e., postabsorptive) period followed by a glucose clamp. As shown in Table II , the same rate of glucose uptake was achieved during all three glucose clamps by raising either the glucose level (designated clamp "G") or the insulin level (clamp "I") in the NIDDM subjects approximately fourfold above the levels used in the control subjects.
Each study was performed after a 12-14 h overnight fast. On the tDetermined by underwater weighing with correction for residual lung volume (24) . P < 0.005 from control subjects. "P < 0.05 from control subjects. The hand was kept in a warming device at 60-70'C to achieve arterialization ofvenous blood for sampling (25) . Each experiment lasted an average of 7.5 h: a 2.5-h basal period followed by a 5-h clamp. A summary of the study procedures is given in Fig. 1 (31) .
Indirect calorimetry: determination ofglucose, fat and protein oxidation. Respiratory exchange measurements were made during the last hour ofboth the basal and clamp periods using an open-circuit indirect calorimeter. A constant fraction ofthe air expired by the subject from a transparent ventilated hood was desaturated, filtered, and analyzed for oxygen (02) and carbon dioxide (C02)-02 was measured by a magnetopneumatic Magnos 4G and CO2 by an infrared Uras 3G (Hartmann and Braun, Frankfurt, FRG). Standard gas mixtures of 20.00% 02 and 1.00% CO2 were used to calibrate the analyzers before and after each study. Acetone, which has an respiratory quotient (CO2 production/02 consumption) of 0.75, was burned in a container inside the hood before and after each study to check the complete system of indirect calorimetry. Before and after the subject was removed from the headbox, blood was collected to measure urea, and urine was collected for analysis of creatinine, urea, and uric acid. After correcting for changes in urea clearance (32) , the nitrogen in these three compounds was combined to give total urinary nitrogen excretion (N, in grams per minute). This was used to calculate the rate of protein oxidation (P.,,) where P.,, = 6.25 X N. From the mean rates of 02 consumed (VO2, in liters per minute) and CO2 produced (VCO2) the rates ofglucose (Go,,) and fat (Fo0) oxidized in milligrams per kilogram of FFM per minute were calculated using the following equations:
(1)
Since approximately 72% of the plasma glucose turnover is derived from glycogen in the basal state (33) Glycogen synthase determination. At the end of a basal period and each clamp study, percutaneous muscle biopsies were obtained on alternating thighs from the vastus lateralis muscle with a 5-mm diam side-cutting needle using a modification of the procedure described by Bergstrom (37) . The skin and fascia 12-16 cm above the patella on the lateral aspect ofthe thigh was anesthetized with 2-3 ml of2% xylocaine without epinephrine and a small incision made through the skin with a scalpel. The biopsy needle was inserted 3-5 cm beyond the fascia into the muscle and three rapid passes made to yield muscle samples of 50-75 mg in size. The specimen was blotted, frozen in liquid nitrogen within 10 s, and stored in liquid nitrogen until assayed. Glycogen synthase (EC 2.4.1.11) was measured using modifications of the methods of Nuttall et al. (38) and Thomas et al. (39) .
Muscle samples (50 mg) were homogenized at 4VC with an extraction buffer at pH 7.4 (2 mmol/liter of EDTA and 1,4-dithiothreitol, 20 mmol/liter NaF, and 50 mmol/liter KH2PO4 and K2HPO4). After centrifugation (20, mmol/liter of G6P. This is believed to be a sensitive indicator of changes in glycogen synthase activity in vivo (41) .
Statistical analysis. All data are expressed as mean±SEM. Data calculations and statistical analysis were performed using the StatView program (BrainPower Inc., Calabasas, CA). Statistical significance was tested using analysis of variance followed by Student's two-tailed t test.
Results
Rates ofglucose uptake. Fig. 2 illustrates the rates of glucose uptake (GU) in the control and NIDDM subjects under basal and clamp conditions. Basal GU was 49% greater in the NIDDM subjects (2.52±0.09 vs. 3.75±0.23 mg/kg FFM per min, P < 0.005). During the clamp in the control subjects, GU was increased to 7.62±0.62 mg/kg FFM per min by raising the serum insulin level to 309 pmol/liter while clamping the glucose concentration at basal levels of 5.1 mmol/liter (Table III) . To achieve the same glucose uptake rate in the NIDDM subjects as the control subjects required plasma glucose levels to be raised an additional -15 mmol/liter (in clamp G) or insulin raised -1,000 pmol/liter (in clamp I) above the levels used in the control subjects (Table III) . This produced glucose uptake rates of 8.62±0.49 (clamp G) and 8.59±0.51 (clamp I) in the NIDDM subjects (both P = NS compared to controls).
Rates ofglucose oxidation. Although basal glucose uptake in the NIDDM subjects was greater than the controls, basal glucose oxidation (G.5) was 28% less in the NIDDM subjects (1.83±0.11 vs. 1.31±0.13 mg/kg FFM per min, P < 0.005).
This defect in G.5 is shown in Fig. 3 (Fig. 3) . Therefore, under basal conditions and both clamp conditions, irrespective of whether glucose uptake was stimulated by either hyperglycemia or hyperinsulinemia, glucose oxidation was reduced by 26-28% in the NIDDM subjects.
Rates offat oxidation. As illustrated in Fig. 4 Figure 5 . Rates of nonoxidative glucose metabolism (N.x) in the control and NIDDM subjects under basal and clamp conditions. Nonoxidative glucose metabolism in the NIDDM subjects was over three times higher under basal conditions (****P < 0.005), 63%
higher under hyperglycemic clamp conditions (clamp G, **P < 0.025), and 65% higher under hyperinsulinemic clamp conditions (clamp I, ***P < 0.01).
measured glycogen synthase activity in muscle since this enzyme is assumed to determine the amount of glycogen stored in muscle (42) and glycogen synthesis is believed to be the major component of No, (43 Fig. 7 . Circulating basal plasma lactate levels were 50% higher in the NIDDM compared to control subjects (0.8±0.1 vs. 1.2+0.1, P < 0.01). When glucose uptake was stimulated by hyperglycemia in the NIDDM subjects (clamp G), lactate levels increased by 91% compared to the control clamp levels (1.1±0.1 vs. 2.1±0.1, P < 0.005). When glucose uptake was stimulated by hyperinsulinemia (clamp I), lactate levels in the NIDDM subjects also increased although to a lesser extent (36%, 1.1±0.1 vs. 1.5±0.1, P < 0.05). Within the NIDDM group lactate levels were significantly higher when glucose uptake was stimulated by hyperglycemia vs. hyperinsulinemia (2.1±0.1 vs. 1.5±0.1, P < 0.01).
Discussion
Many studies have shown that rates of intracellular glucose metabolism are lower in NIDDM subjects than nondiabetic subjects (2, 3, 5, 6) . However, reduced rates of glucose oxidation and nonoxidative glucose metabolism in these studies have always been accompanied by reduced rates of glucose uptake, therefore making it impossible to determine whether these reduced rates of glucose metabolism are due to intracellular defects or simply a result of less glucose entering the cell. To overcome this problem, we measured rates of intracellular glucose metabolism when stimulated rates of glucose uptake were matched in age-sex and weight-matched NIDDM and nondiabetic control subjects. This was achieved by either raising the serum glucose or insulin concentration in the NIDDM subjects fourfold higher than the control subjects. Our results clearly show that rates of glucose oxidation are dramatically
Control NIDD NIDD Clamp Clamp G Clamp Figure 7 . Plasma lactate concentrations in the control and NIDDM subjects under basal and clamp conditions. Basal lactate levels were 50% higher in the NIDDM compared to control subjects (***P < 0.01). Lactate levels in the NIDDM subjects were 91% higher under hyperglycemic conditions (****P < 0.005) and 36% higher under hyperinsulinemic conditions (*P < 0.05) compared to nondiabetic subjects. Within the NIDDM subjects, lactate levels were higher under hyperglycemic compared to hyperinsulinemic conditions (***, P < 0.01). L, liter.
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Thorburn et al. reduced in nonobese NIDDM subjects even when the rate of whole-body glucose uptake is matched to that of control subjects. Furthermore, the magnitude of this defect is the same whether glucose uptake is stimulated by either hyperglycemia or hyperinsulinemia, and occurs despite normal fat oxidation rates. These lower rates of glucose oxidation in NIDDM subjects are accompanied by higher rates of nonoxidative glucose metabolism when glucose uptake is matched to control subjects. Muscle glycogen synthase activity, however, is 41% lower when insulin levels are the same. Unlike glucose oxidation, this reduced glycogen synthase activity can be overcome by raising insulin concentrations fourfold.
Whole-body glucose oxidation is reduced by the same amount (26-28%) in NIDDM compared to nondiabetic subjects under both basal and stimulated flux conditions despite glucose uptake being higher (under basal conditions) or the same (under clamp conditions). These results indicate that the defect in glucose oxidation cannot be overcome by increasing the rate of glucose uptake or the serum concentrations of glucose or insulin. Although the individual tissues responsible for this oxidative defect cannot be determined from the current studies, available evidence indicates that it is most likely to occur predominantly in skeletal muscle. This conclusion is based on regional catheterization studies conducted under conditions similar to those of the current study. These catheterization studies have shown that -90% ofthe glucose taken up under hyperinsulinemic euglycemic conditions (e.g., clamp I and control study) is disposed of by muscle (1, 44) . Similarly, under hyperglycemic conditions (e.g., in clamp G) the vast majority (80%) of glucose taken up is disposed of by muscle (44) . Even if this 10% difference in muscle glucose uptake under hyperglycemic (clamp G) or hyperinsulinemic (control clamp) conditions were taken up by tissues with no oxidative capacity, this cannot explain the 26% difference observed in glucose oxidation between the NIDDM and control subjects. Based on this line of reasoning, it seems likely that the oxidative defect in glucose metabolism occurs predominantly in skeletal muscle tissue.
Although our study was not designed to locate the metabolic abnormality which underlies the defect in glucose oxidation in NIDDM, some clues as to where the defect does not occur can be determined from our data. Impaired fat oxidation was not responsible for the defect in glucose oxidation since rates of fat oxidation were identical in the NIDDM and control subjects under both basal and stimulated rates of glucose uptake. The similarity in fat oxidation rates and free fatty acid levels in control and NIDDM subjects despite reduced rates ofglucose oxidation in the NIDDM subjects in our study is supported by the findings of a number of researchers who have shown that fat metabolism in non-obese NIDDM subjects is normal despite impaired insulin-mediated glucose utilization (3) (4) (5) (45) (46) (47) . Therefore, in nonobese NIDDM subjects, the defect in glucose oxidation is not associated with increased fat oxidation. The situation in NIDDM subjects who are also obese may differ, however, since a disturbance in fat metabolism in these subjects may cause an additional defect in glucose oxidation (21, 22) .
Defects in glucose uptake were also not responsible for reduced glucose oxidation in the NIDDM subjects since reduced glucose oxidation occurred when rates ofglucose uptake were normalized. This data strongly supports the notion that glucose oxidation does not regulate the rate of glucose uptake in nonobese NIDDM individuals under either hyperglycemic or hyperinsulinemic conditions.
The likely cause ofreduced glucose oxidation in NIDDM is a defect in the activity of the pyruvate dehydrogenase (PDH) complex. There is some published data which has shown that a defect in PDH activity exists in NIDDM which cannot be overcome by increasing the ambient insulin concentration (48) (49) (50) . This would explain why no improvement in glucose oxidation was observed in the present study when insulin concentrations were increased fourfold in the NIDDM subjects. Further studies, particularly those directed at PDH activity, will be needed to define the exact cause of reduced glucose oxidation in NIDDM.
In addition to defects in oxidative glucose metabolism, defects in total nonoxidative glucose metabolism have been reported in NIDDM (2) (3) (4) (5) (6) (7) 15) . The close correlations found between decreases in nonoxidative glucose metabolism and decreases in insulin-mediated glucose uptake (2-10) have lead several investigators to speculate that defects in nonoxidative glucose metabolism may be the cause of reduced rates of glucose uptake in NIDDM and other states of insulin resistance (7, (10) (11) (12) (13) (14) (15) . However, the reduced non-oxidative glucose metabolism could simply be a result of reduced glucose uptake rather than an independent defect in NIDDM. We were able to address this issue in the present study by matching rates of glucose uptake in NIDDM and nondiabetic subjects. When glucose uptake rates were identical in NIDDM and control subjects the decreases in nonoxidative glucose metabolism which others have reported in NIDDM (2-7, 15) did not exist. In fact, the amount of glucose entering nonoxidative metabolism in the NIDDM subjects was 63-65% greater than the control subjects when glucose uptake was normalized using either hyperglycemia or hyperinsulinemia. These data suggest that insulin has no intracellular effect on the absolute rate of nonoxidative glucose metabolism. Since total nonoxidative glucose metabolism was greater in the NIDDM subjects when glucose uptake was the same as the control subjects, this pathway of glucose metabolism appears to serve simply as a reservoir for glucose which enters the cell and cannot be oxidized rather than a regulator of glucose uptake. Therefore, in contrast to the speculation recently raised concerning a rate-limiting role for nonoxidative glucose metabolism on glucose uptake (7, (10) (11) (12) (13) (14) (15) , our data strongly suggest that total nonoxidative glucose metabolism, like glucose oxidation, plays no role in determining the rate of glucose uptake under physiologic conditions of hyperglycemia and hyperinsulinemia.
Nonoxidative glucose metabolism may be composed of glycogen and lipid synthesis, nonoxidative glycolysis to lactate, and the pentose phosphate shunt. Of these components only glycogen synthesis and lactate formation are likely to be significant under our study conditions since no net lipogenesis (respiratory quotient > 1.0 [8] ) was detected and the pentose phosphate shunt is negligible in muscle tissue (51) . To further characterize the composition of nonoxidative glucose metabolism, muscle glycogen synthase activity was measured since this enzyme is assumed to be the major determinant of glycogen deposition in muscle (7, 42) . Although the rate of nonoxidative glucose metabolism was greater in the NIDDM subjects, the activity of glycogen synthase was lower under basal conditions and during the clamps when insulin levels were the same. This was a surprising finding since glycogen synthesis is thought to be the major component of nonoxidative glucose metabolism (43) . Unlike previous studies which have shown reduced glycogen synthase activity under conditions of reduced glucose uptake and reduced nonoxidative glucose metabolism (7, 10) , our study is the first to demonstrate that this reduced activity occurs independent of changes in glucose uptake and in the presence of increased total nonoxidative glucose metabolism. In support of our findings, Wright et al. (52) have shown that 90 minutes after a meal, when insulin concentrations are the same but glucose concentrations are significantly higher (like clamp G), muscle glycogen synthase activity is lower in NIDDM compared to control subjects. In the present study, raising the insulin level approximately fourfold in the NIDDM subjects (clamp I) normalized the glycogen synthase activity to that of the control group. These data suggest that the sensitivity of glycogen synthase to insulin is lower in NIDDM compared with control subjects. Since this occurs independent of changes in glucose uptake, insulin rather than glucose availability appears to be the primary regulator of glycogen synthase in NIDDM.
Since glucose uptake was comparably stimulated, glucose oxidation comparably defective, and glycogen synthesis was not increased during the clamps in the NIDDM subjects, one would expect the remaining glucose taken up to enter the only other intracellular pathway available, namely nonoxidative glycolysis to lactate. The lactate data collected in the present study shows this to be the case. Circulating plasma lactate levels were significantly higher during both clamps in the NIDDM subjects than in control subjects. Given that less glucose enters glycogen synthesis in hyperglycemic clamp G than hyperinsulinemic clamp I in the NIDDM subjects it also seems reasonable that lactate levels be significantly higher in clamp G than clamp I, as our data has shown. Under basal conditions, the increase in nonoxidative glucose metabolism was also accompanied by increases in plasma lactate levels in the NIDDM compared to control subjects, as previously reported by other investigators (53) (54) (55) . Thus, the mechanisms of increased nonoxidative glucose metabolism under both basal and stimulated conditions in NIDDM is not into glycogen synthesis but primarily into lactate.
In summary, the results of this study indicate that a defect in the oxidative pathway results in reduced glucose oxidation in nonobese NIDDM subjects which is independent of fat oxidation or impaired glucose uptake. A decrease in the sensitivity of glycogen synthase to insulin also appears to exist in NIDDM which is independent of insulin's effect on glucose uptake. However, this defect, unlike glucose oxidation, can be overcome by increasing the insulin concentration. The findings that glucose oxidation and glycogen synthase activity are reduced and nonoxidative glucose metabolism is increased in NIDOM subjects when rates ofglucose uptake are normalized to nondiabetic rates suggests that some step proximal to the intracellular metabolism of G6P is rate-limiting for overall glucose uptake.
